DAVID MARK EPSTEIN : Citation Profile


Are you DAVID MARK EPSTEIN?

Universidad de Granada

8

H index

4

i10 index

141

Citations

RESEARCH PRODUCTION:

20

Articles

4

Papers

RESEARCH ACTIVITY:

   16 years (2005 - 2021). See details.
   Cites by year: 8
   Journals where DAVID MARK EPSTEIN has often published
   Relations with other researchers
   Recent citing documents: 9.    Total self citations: 4 (2.76 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pep15
   Updated: 2022-08-06    RAS profile: 2021-10-10    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with DAVID MARK EPSTEIN.

Is cited by:

Walker, Simon (4)

Gomes, Manuel (3)

Schreyögg, Jonas (3)

Claxton, Karl (3)

Lusk, Jayson (2)

Costa-Font, Joan (2)

Asaria, Miqdad (2)

Sculpher, Mark (2)

Soares, Marta (2)

Faria, Rita (2)

Hernández-Quevedo, Cristina (2)

Cites to:

Claxton, Karl (12)

Sculpher, Mark (6)

Gertler, Paul (3)

Wagstaff, Adam (3)

Case, Anne (3)

Contoyannis, Paul (2)

Weil, David (2)

Husereau, Don (2)

Galiani, Sebastian (2)

Ashraf, Quamrul (2)

Johannesson, Magnus (2)

Main data


Where DAVID MARK EPSTEIN has published?


Journals with more than one article published# docs
Health Economics5
The European Journal of Health Economics3
PharmacoEconomics2

Working Papers Series with more than one paper published# docs
FEG Working Paper Series / Faculty of Economics and Business (University of Granada)2
Working Papers / Centre for Health Economics, University of York2

Recent works citing DAVID MARK EPSTEIN (2022 and 2021)


YearTitle of citing document
2021Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies. (2021). Borsoi, Ludovica ; Banks, Helen ; Armeni, Patrizio ; Amatucci, Fabio ; Tarricone, Rosanna ; Marletta, Marcella ; Torbica, Aleksandra ; Federici, Carlo ; Costa, Francesco ; Ciani, Oriana ; Callea, Giuditta. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:5:p:602-608.

Full description at Econpapers || Download paper

2021Taking a local government perspective for economic evaluation of a population-level programme to promote exercise. (2021). Bojke, Laura ; Hill, Andrew J ; Meads, David ; Candio, Paolo. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:5:p:651-657.

Full description at Econpapers || Download paper

2021Computing the value of information from periodic testing in holistic decision making under uncertainty. (2021). Banisoleiman, Kian ; Gonzlez, Arturo ; Faber, Michael Havbro ; Zou, Guang. In: Reliability Engineering and System Safety. RePEc:eee:reensy:v:206:y:2021:i:c:s0951832020307420.

Full description at Econpapers || Download paper

2021Incorporating Process Utility into Cost-Effectiveness Analysis via a Bolt-On Domain to the SF-6D: An Exploratory Study. (2021). Jones, Georgina ; Brennan, Victoria K ; Dixon, Simon ; Radley, Stephen. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:5:d:10.1007_s40258-021-00646-4.

Full description at Econpapers || Download paper

2021Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions. (2021). Wilkinson, Clare ; Sutton, Alex J ; Hughes, Dyfrig ; Lewis, Ruth A. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00980-w.

Full description at Econpapers || Download paper

2021Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study. (2021). Alshreef, Abualbishr ; Yang, Yit ; Pennington, Becky ; Kelly, Joanna ; Murphy, Caroline ; Vasconcelos, Joana C ; Prevost, Toby A ; Sivaprasad, Sobha ; Hykin, Philip ; Poku, Edith ; Brazier, John ; Metry, Andrew ; Williams, Michael ; Flight, Laura ; Lotery, Andrew . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:8:d:10.1007_s40273-021-01026-5.

Full description at Econpapers || Download 2021

Sure independence screening in the presence of missing data. (2021). Matthews, Gregory J ; Zambom, Adriano Zanin. In: Statistical Papers. RePEc:spr:stpapr:v:62:y:2021:i:2:d:10.1007_s00362-019-01115-w.

Full description at Econpapers || Download paper

2021Flexible Bayesian longitudinal models for cost?effectiveness analyses with informative missing data. (2021). Mason, Alexina J ; Grieve, Richard ; Carpenter, James ; Gomes, Manuel. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:12:p:3138-3158.

Full description at Econpapers || Download paper

2021Balancing health and financial protection in health benefit package design. (2021). Lofgren, Katherine T ; Verguet, Stephane ; Salomon, Joshua A ; Memirie, Solomon T ; Watkins, David A. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:12:p:3236-3247.

Full description at Econpapers || Download paper

Works by DAVID MARK EPSTEIN:


YearTitleTypeCited
2014A comparison of the accuracy of liquid cytology versus conventional screening: a meta-analysis of split-sample studies In: Journal of the Royal Statistical Society Series A.
[Full Text][Citation analysis]
article0
2008Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions In: Working Papers.
[Full Text][Citation analysis]
paper9
2010Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions.(2010) In: Journal of Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 9
article
2009An economic framework for analysing the social determinants of health and health inequalities In: Working Papers.
[Full Text][Citation analysis]
paper0
2008Uncertainty and value of information when allocating resources within and between healthcare programmes In: European Journal of Operational Research.
[Full Text][Citation analysis]
article9
2016Effectiveness of treatments of varicose veins. Systematic review and evidence synthesis In: FEG Working Paper Series.
[Full Text][Citation analysis]
paper0
2016Health Related Quality of Life after Surgical Repair of Asymptomatic Abdominal Aortic Aneurysms In: FEG Working Paper Series.
[Full Text][Citation analysis]
paper0
2006Costs and prices for inpatient care in England: Mirror twins or distant cousins? In: Health Care Management Science.
[Full Text][Citation analysis]
article12
2005Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults: The Results of a Probabilistic Decision Model In: Medical Decision Making.
[Full Text][Citation analysis]
article4
2005Cost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response In: Medical Decision Making.
[Full Text][Citation analysis]
article8
2007Efficiency, Equity, and Budgetary Policies In: Medical Decision Making.
[Full Text][Citation analysis]
article15
2013Use of Multiparameter Evidence Synthesis to Assess the Appropriateness of Data and Structure in Decision Models In: Medical Decision Making.
[Full Text][Citation analysis]
article1
2017A Procedure for Deriving Formulas to Convert Transition Rates to Probabilities for Multistate Markov Models In: Medical Decision Making.
[Full Text][Citation analysis]
article1
2021Consumers Preferences and Willingness to Pay for Personalised Nutrition In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2016Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2020A general framework for classifying costing methods for economic evaluation of health care In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2021Correction to: A general framework for classifying costing methods for economic evaluation of health care In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2012Golimumab for the Treatment of Psoriatic Arthritis In: PharmacoEconomics.
[Full Text][Citation analysis]
article26
2014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials In: PharmacoEconomics.
[Full Text][Citation analysis]
article29
2008The hospital costs of care for stroke in nine European countries In: Health Economics.
[Full Text][Citation analysis]
article9
2009Social determinants of health: an economic perspective In: Health Economics.
[Full Text][Citation analysis]
article8
2014COMMENT ON ‘HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH’ In: Health Economics.
[Full Text][Citation analysis]
article0
2017Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs In: Health Economics.
[Full Text][Citation analysis]
article9
2019Beyond the cost?effectiveness acceptability curve: The appropriateness of rank probabilities for presenting the results of economic evaluation in multiple technology appraisal In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated August, 1st 2022. Contact: CitEc Team